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chocardiographic Findings and
he Search for a Gold Standard in
atients With Arrhythmogenic
ight Ventricular Dysplasia*
elvin M. Scheinman, MD, FACC,
ichael H. Crawford, MD, FACC
an Francisco, California
he proper diagnosis of patients with arrhythmogenic right
entricular dysplasia (ARVD) remains an important prob-
em. This is due to the fact that, unfortunately, no gold
tandard exists for making the diagnosis of ARVD. As such,
e rely on Task Force criteria for making this diagnosis (1).
lthough the Task Force criteria are of value in allowing
ifferent investigators to use a set of homogeneous criteria,
hey are clearly imperfect as a true gold standard. Confor-
ity does not necessarily mean accuracy.
See page 860
A positive diagnosis is made with presence of two major,
ne major and two minor, or four minor criteria. A close
ook at the criteria reveals flaws in practical application. For
xample, minor right ventricular (RV) wall-motion abnor-
alities are considered a minor criterion, but this involves
ubjective interpretation of what constitutes “mild.” So, for
xample, a patient who has “mild” RV wall-motion abnor-
alities, sustained left bundle branch block ventricular
achycardia (minor), and inverted T waves in electrocardio-
raphic leads V2 to V3 (minor) would not be diagnosed as
aving RV dysplasia (three minor criteria). However, a
atient with severe RV dilatation and dysfunction (major),
requent extrasystoles on monitoring (minor), and T-wave
nversions in V2 to V3 (minor) would. Thus, the accurate
haracterization of the echo findings becomes crucial.
In this issue of the Journal, the article by Yoerger et al. (2)
rom the National Institutes of Health (NIH)-funded
RVD study makes important strides in clarifying the
chocardiographic criteria. First, these investigators deter-
ined quantitative criteria for defining abnormal RV size
nd function. They found, for example, that diastolic
ilation of the RV outflow tract in the parasternal long axis
iew (30 mm) was the most common abnormality occur-
ing in 100% of the probands. Second, they clarified the
trength of abnormal RV morphology in establishing the
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the University of California, San Francisco, California. Dr. Scheinman is at
o-investigator on the National Institutes of Health Arrhythmogenic Right Ventric-
lar Dysplasia study.iagnosis. For example, anterior RV wall-motion abnormal-
ties were common (70%), abnormally prominent trabecu-
ations were seen in the majority (54%), and sacculations
ere seen in 17%. None of the normal controls had these
ore specific findings.
Several points should be made in reference to this
ontribution. Firstly, the diagnosis was made on the basis of
ask Force criteria independent of the echo findings in 28
f 29 patients. This is an eminently reasonable approach
hen trying to assess the value of echocardiographic find-
ngs but introduces a bias in the sense that the patients
ncluded may have had established disease, sufficiently
dvanced to be manifest using other morphologic criteria
presumably derived from RV angiography or cardiac mag-
etic resonance imaging [MRI]). The equally critical issue
elative to the echocardiographic findings of ARVD in
atients with mild disease is not addressed in this report.
Currently, three genetic mutations have been described as
auses of 30% to 50% of patients with ARVD (3). These
nclude mutations in genes that control cell-to-cell adhesion
unctions (i.e., plakoglobin, desmoplakin, or plakophillin) or
bnormalities in the ryanodine receptor. These genetic
bnormalities allow investigators to precisely track develop-
ent of ARVD. For example, in those with Naxos disease
plakoglobin mutation) (4), the disease phenotype does not
ppear until adolescence. In addition, sudden cardiac death
as been reported in athletes who have very mild or
napparent structural abnormalities (5) and emphasizes the
mportance of detecting the subtle early findings.
The investigators found that dilation of the RV outflow
ract (30 mm) using the parasternal view was an excellent
arameter for diagnosing ARVD in the appropriate setting.
ne of the most important confounding diagnoses that a
linician must distinguish from ARVD is that of RV
utflow tract ventricular tachycardia. Others using MRI
tudies have found evidence of RV outflow dilation in
atients with RV outflow tract ventricular tachycardia (6).
he distinction between these two entities is very important
ince RV outflow tract ventricular tachycardia is usually
enign and often responds to ablative therapy. It is hoped
hat further experience from the NIH study group will allow
s to better distinguish these two diagnoses. The finding of
iffuse global and/or major segmental RV abnormalities will
learly favor ARVD. However, the issue of presentation of
he patient with less advanced disease still remains an
mportant problem.
Another significant problem with the report by Yoerger
t al. (2) is lack of correlative information vis-à-vis other
nvasive and non-invasive testing. This information was not
resented because of the nature of the study protocol.
herefore, we avidly look forward to future reports where
chocardiographic findings can be correlated with other
bnormalities.
Finally, we hope the real value of the NIH studies is thathey will ultimately provide for a large cohort of patients in
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March 15, 2005:866–7 Editorial Commenthom the diagnosis of ARVD is more secure, either on the
asis of cardiac histology (which is part of the registry
rotocol) (7), after prolonged follow-up observations, or
ith genetic testing. The correlation of existing data with a
ruer gold standard would be clearly an important advance.
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